Synthesis and initial PET imaging of new potential NK1 receptor radioligands 1-[2-(3,5-bis-trifluoromethyl-benzyloxy)-1-phenyl-ethyl]-4-[11C]methyl-piperazine and {4-[2-(3,5-bis-trifluoromethyl-benzyloxy)-1-phenyl-ethyl]-piperazine-1-yl}-acetic acid [11C]methyl ester

This publication has 23 references indexed in Scilit:

• Synthesis and characterization of a potent, selective, radiolabeled substance-P antagonist for NK receptor quantitation: ([F]SPA-RQ)
  Molecular Imaging & Biology, 2004
• AB INITIO MO CALCULATION STUDIES FOR SEVERAL NOVEL ENTRIES TO TROPANE COMPOUNDS
  Journal of Theoretical and Computational Chemistry, 2004
• PET evaluation of the uptake of N-[11C]methyl CP-643,051, an NK1 receptor antagonist, in the living porcine brain
  Nuclear Medicine and Biology, 2004
• Discovery of orally bioavailable NK1 receptor antagonists
  Bioorganic & Medicinal Chemistry Letters, 2003
• Receptor 1980 and Receptor 2000: twenty years of progress in receptor-binding radiotracers
  Nuclear Medicine and Biology, 2001
• Brain uptake and receptor binding of two [11C]labelled selective high affinity NK1-antagonists, GR203040 and GR205171 — PET studies in rhesus monkey
  Neuropharmacology, 2000
• PET imaging of the pre-synaptic dopamine uptake sites in rapid-onset dystonia-parkinsonism (RDP)
  Movement Disorders, 1999
• Improved synthesis of β-CIT and [11C]β-CIT labeled at nitrogen or oxygen positions
  Nuclear Medicine and Biology, 1996
• Synthesis of a 11C-labeled NK1 receptor ligand for PET studies
  Nuclear Medicine and Biology, 1995
• Synthesis of a nonpeptide carbon-11 labeled substance P antagonist for PET studies
  Nuclear Medicine and Biology, 1993